SEC Form 4 · accession 0001179110-15-012850
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Period of report
Aug 31, 2015
Accepted (ET)
Sep 2, 2015 · 2:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 31, 2015 | S | 16,218 | $38.7508 | D | 88 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 15,877 Common Shares sold directly by Sevin Rosen Fund IX L.P. and 341 Common Shares sold directly by Sevin Rosen IX Affiliates Fund L.P. pursuant to Rule 144 under the Securities Act of 1933, as amended.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at pricing ranging from $38.61 to $38.92 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.